Iovance Biotherapeutics Inc. Common Stock vs James Hardie Industries plc. Ordinary Shares — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.59 (market cap $6.04B), while James Hardie Industries plc. Ordinary Shares trades at $25.06 (market cap $14.60B). The key difference: James Hardie Industries plc. Ordinary Shares is far larger — about 2.4× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, James Hardie Industries plc. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and James Hardie Industries plc. Ordinary Shares for 1 Days on average.
| IOVA | JHX | |
|---|---|---|
Market Cap | $6.04B | $14.60B |
Volume | 14,805,993 | 7,262,924 |
Sector | Health | Basic Materials |
52-Week High | $14.82 | $31.08 |
52-Week Low | $1.81 | $16.69 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $5.97B | $18.83B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →James Hardie manufactures fiber cement products for residential and commercial construction. Its portfolio includes exterior siding, interior boards, and other building materials.
Read more on JHX →